Connect Biopharma Holdings Ltd — Investor Relations & Filings
Filings indexed
163
across all filing types
Latest filing
2026-05-12
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
CNTB
Connect Biopharma Holdings Ltd. is a global, clinical-stage biopharmaceutical company dedicated to developing therapies for T cell-driven inflammatory diseases. The company focuses on discovering and advancing next-generation immune modulators to treat chronic conditions, with a particular emphasis on respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody targeting the interleukin-4 receptor alpha (IL-4Rα), which is being evaluated for its potential in treating various inflammatory diseases. The company aims to address significant unmet medical needs by advancing its pipeline of innovative therapeutics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Connect Biopharma Holdings Ltd (0001835268) (Filer) | 2026-05-12 | English | |
| 8-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | 2026-05-12 | English | |
| 8-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | 2026-04-23 | English | |
| 8-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | 2026-03-30 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 45273224 | 10-Q - Connect Biopharma Holdings Ltd (0001835268) (Filer) | 2026-05-12 | English | ||
| 45273085 | 8-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | 2026-05-12 | English | ||
| 35731282 | 8-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | 2026-04-23 | English | ||
| 33087303 | 8-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | 2026-03-30 | English | ||
| 31989017 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31989001 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31988999 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
8 filings
| |||||
| 13347973 | 8-K | 2025-12-23 | English | ||
| 13347974 | Major Shareholding Notification 2025 | 2025-11-28 | English | ||
| 13347975 | Major Shareholding Notification 2025 | 2025-11-26 | English | ||
| 13347976 | Regulatory Filings 2025 | 2025-11-25 | English | ||
| 13347977 | Regulatory Filings 2025 | 2025-11-21 | English | ||
| 13347978 | Regulatory Filings 2025 | 2025-11-18 | English | ||
| 13347981 | 10-Q | 2025-11-12 | English | ||
| 13347982 | 8-K | 2025-11-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Connect Biopharma Holdings Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34392/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34392 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34392 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34392 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34392}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Connect Biopharma Holdings Ltd (id: 34392)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.